Defendants Seek Full Genetic Testing In Louisiana Asbestos Lung Cancer Suit
NEW ORLEANS — Companies embroiled in a Louisiana take-home asbestos lung cancer suit moved to compel production of a blood sample for whole genome sequencing, pointing out that limited testing on...To view the full article, register now.
Already a subscriber? Click here to view full article